Study to test RC220 alongside standard-of-care osimertinib to prevent or delay treatment resistance. ... Read More The post Racura secures green light for RC220 HARNESS-1 lung cancer trial appeared ...

The biopharmaceutical firm Cnbx Pharmac.ew finds itself at a critical juncture. The company's future valuation is increasingly tied to two imminent catalysts: t ...